AIRS Medical Launches SwiftMR® and SwiftSight to Advance Brain Health Monitoring

AIRS Medical is tackling a longstanding challenge in neuroimaging—tracking brain health consistently across time and MRI systems—with the launch of its integrated imaging ecosystem: SwiftMR® and SwiftSight.

SwiftMR®, the company’s MRI enhancement solution, accelerates scan times by up to 50% while simultaneously improving image quality. Complementing it is SwiftSight, an analytics platform that transforms imaging data into meaningful, quantitative insights for clinicians.

Together, the tools are designed to help healthcare providers monitor changes in brain health with greater precision—regardless of scanner type or location. This means more reliable tracking of neurological conditions like Alzheimer’s disease and dementia, which often require long-term observation to guide diagnosis and treatment decisions.

“SwiftSight was developed to give providers a clearer view of brain changes over time,” said Jina Park, Chief Strategy Officer at AIRS Medical. “As someone who has witnessed the devastating impact of Alzheimer’s and dementia, this launch is deeply personal. We built this platform because it’s the kind of tool we would want for ourselves and for our families.”

SwiftSight’s ability to generate consistent data across different MRI systems aims to remove a major barrier in longitudinal brain studies and routine clinical care. In doing so, it empowers both clinicians and patients with a clearer, more actionable understanding of neurological health.